Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Change in Accured Expenses (2022 - 2025)

OneMedNet has reported Change in Accured Expenses over the past 4 years, most recently at $314000.0 for Q4 2025.

  • Quarterly Change in Accured Expenses rose 1262.96% to $314000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $366000.0 through Dec 2025, down 69.65% year-over-year, with the annual reading at $366000.0 for FY2025, 69.65% down from the prior year.
  • Change in Accured Expenses was $314000.0 for Q4 2025 at OneMedNet, down from $432000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $570000.0 in Q2 2024 and troughed at -$744114.0 in Q4 2022.
  • The 4-year median for Change in Accured Expenses is $277000.0 (2023), against an average of $169000.0.
  • Year-over-year, Change in Accured Expenses skyrocketed 7025.0% in 2024 and then plummeted 204.56% in 2025.
  • A 4-year view of Change in Accured Expenses shows it stood at -$744114.0 in 2022, then soared by 150.66% to $377000.0 in 2023, then tumbled by 107.16% to -$27000.0 in 2024, then soared by 1262.96% to $314000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Change in Accured Expenses are $314000.0 (Q4 2025), $432000.0 (Q3 2025), and -$596000.0 (Q2 2025).